Racke, Michael K Niles, Justin K Lorenz, Raymond A Kaufman, Harvey W
Published in
Journal of neuroimmunology
Reports suggested an association between SARS-CoV-2 infection and GBS, but subsequent studies produced conflicting results regarding the incidence of GBS during the pandemic. This study assessed positivity rates for GQ1b, GM-1, GD1a, and GD1b for tests performed January 2016, through March 2021, at a national laboratory. Relative to pre-pandemic le...
Galassi, Giuliana
Published in
Journal of Neuroimmunology
Diaz, Pablo Leveque, Marie Hautecloque, Geoffroy Sellal, François Augereau, Olivier Lita, Livinia Biegle, Estelle Belilita, Lounis Bouterra, Charles Rerat, Pierre
...
Published in
Journal of neuroimmunology
Various neurological complications have been described in COVID-19 patients, especially Guillain-Barre syndrome (GBS). The underlying mechanisms on the association between SARS-CoV-2 infection and GBS remain unclear, but several hypotheses have been proposed. It seems that post-SARS-CoV-2 GBS shares many characteristics with classic post-infectious...
Asaduzzaman, Md Purkayastha, Bidrum Alam, M. M. Jahangir Chakraborty, Shishir Ranjan Roy, Soumitra Ahmed, Nasad
Published in
Journal of Neuroimmunology
Introduction Large-scale vaccination is considered one of the most effective strategies to control the pandemic of COVID-19. Since its start, different complications have been described thought to be related to vaccination. Here, we present a rare case where encephalopathy, myocarditis, and thrombocytopenia developed simultaneously following the se...
Adamec, Ivan Rogić, Dunja Penz, Monika-Gabriele Braun, Carola Habek, Mario
Published in
Journal of neuroimmunology
To report clinical outcome, development of humoral and T-cell mediated immunity in convalescent COVID-19 people with multiple sclerosis (pwMS) treated with ofatumumab in the ALITHIOS study from a single center. Testing for SARS-Cov2 IgG antibodies was performed on two occasions with at least three months apart between the two testing. During the se...
Ismail, Ismail Ibrahim Salama, Sara
Published in
Journal of neuroimmunology
Since the emergency use approval of different types of COVID-19 vaccines, several safety concerns have been raised regarding its early and delayed impact on the nervous system. This study aims to systematically review the reported cases of CNS demyelination in association with COVID-19 vaccination, which has not been performed, to our knowledge. A ...
Caravagna, Céline
Published in
Journal of neuroimmunology
Liu, Luke D Duricka, Deborah L
Published in
Journal of neuroimmunology
After recovering from COVID-19, a significant proportion of symptomatic and asymptomatic individuals develop Long COVID. Fatigue, orthostatic intolerance, brain fog, anosmia, and ageusia/dysgeusia in Long COVID resemble "sickness behavior," the autonomic nervous system response to pro-inflammatory cytokines (Dantzer et al., 2008). Aberrant network ...
Toljan, Karlo Amin, Moein Kunchok, Amy Ontaneda, Daniel
Published in
Journal of neuroimmunology
Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus infection has been reported, and reactivation of MS following non-mRNA COVID-19 vaccination has been noted, but there have only been three reports of newly diagnosed MS following exposure to mRNA COVID-19 vaccine. The association cannot be determined to be causal, as latent...
Achiron, Anat Mandel, Mathilda Dreyer-Alster, Sapir Harari, Gil Dolev, Mark Menascu, Shay Magalashvili, David Flechter, Shlomo Givon, Uri Guber, Diana
...
Published in
Journal of neuroimmunology
Appropriate immune response following COVID-19 vaccination is important in the context of disease-modifying treatments (DMTs). In a prospective cross-sectional study, we determined SARS-COV-2 IgG response up to 6 months following PfizerBNT162b2 vaccination in 414 multiple sclerosis (MS) patients and 89 healthy subjects. Protective response was demo...